American Association for Cancer Research
Browse
21598290cd200473-sup-241154_0_supp_6226302_q8vd8h.docx (12.91 kB)

Supplementary Table from Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19

Download (12.91 kB)
journal contribution
posted on 2023-04-03, 22:25 authored by Sangya Agarwal, Carl H. June

Examples of therapies used for HLH and MAS.

Funding

NIH

Parker Institute for Cancer Immunotherapy

History

ARTICLE ABSTRACT

Cytokine release and macrophage activation contribute to immunopathology after SARS-CoV-2 infection. We discuss approaches to decrease the morbidity and mortality in patients with COVID-19 by repurposing existing drugs previously developed for cancer therapy.

Usage metrics

    Cancer Discovery

    Categories

    Keywords

    ImmunologyCytokinesImmunotherapyCellular immunotherapy

    Licence

    CC BY

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC